These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24726271)

  • 1. Bile acids in cholestasis: bad for the liver, not so good for the kidney.
    Erlinger S
    Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):392-4. PubMed ID: 24726271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice.
    Fickert P; Krones E; Pollheimer MJ; Thueringer A; Moustafa T; Silbert D; Halilbasic E; Yang M; Jaeschke H; Stokman G; Wells RG; Eller K; Rosenkranz AR; Eggertsen G; Wagner CA; Langner C; Denk H; Trauner M
    Hepatology; 2013 Dec; 58(6):2056-69. PubMed ID: 23813550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
    Krones E; Eller K; Pollheimer MJ; Racedo S; Kirsch AH; Frauscher B; Wahlström A; Ståhlman M; Trauner M; Grahammer F; Huber TB; Wagner K; Rosenkranz AR; Marschall HU; Fickert P
    J Hepatol; 2017 Jul; 67(1):110-119. PubMed ID: 28242240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are bile acids involved in the renal dysfunction of obstructive jaundice? An experimental study in bile duct ligated rats.
    Kaler B; Karram T; Morgan WA; Bach PH; Yousef IM; Bomzon A
    Ren Fail; 2004 Sep; 26(5):507-16. PubMed ID: 15526908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholemic Nephropathy: Role in Acute Kidney Injury in Cholestasis and Cirrhosis.
    Pinter K; Rosenkranz A
    Adv Kidney Dis Health; 2024 Mar; 31(2):111-126. PubMed ID: 38649215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid-induced cholemic nephropathy.
    Krones E; Wagner M; Eller K; Rosenkranz AR; Trauner M; Fickert P
    Dig Dis; 2015; 33(3):367-75. PubMed ID: 26045271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenetic aspects of cholemic nephropathy].
    Lenti G; Emanuelli G; Gatti G; Cestonaro G; Calcamuggi G; Anfossi G; Battaglia G; Camussi G; Robecchi A
    Minerva Med; 1978 Oct; 69(47):3203-14. PubMed ID: 362245
    [No Abstract]   [Full Text] [Related]  

  • 8. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Mar; 99():1022-1032. PubMed ID: 29307496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholemic nephropathy - Historical notes and novel perspectives.
    Krones E; Pollheimer MJ; Rosenkranz AR; Fickert P
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1356-1366. PubMed ID: 28851656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholestasis on regulation of cAMP synthesis by glucagon and bile acids in isolated hepatocytes.
    Matsuzaki Y; Bouscarel B; Le M; Ceryak S; Gettys TW; Shoda J; Fromm H
    Am J Physiol; 1997 Jul; 273(1 Pt 1):G164-74. PubMed ID: 9252523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Cast Nephropathy Caused by Obstructive Cholestasis.
    Aniort J; Poyet A; Kemeny JL; Philipponnet C; Heng AE
    Am J Kidney Dis; 2017 Jan; 69(1):143-146. PubMed ID: 27780576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of bile acids in bile duct-ligated rats.
    Takada Y; Sano N; Takikawa H
    J Gastroenterol; 2003; 38(6):561-6. PubMed ID: 12825132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholemic Nephropathy Reloaded.
    Fickert P; Rosenkranz AR
    Semin Liver Dis; 2020 Feb; 40(1):91-100. PubMed ID: 31627236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detour of bile acid routes as therapeutic roadmap for cholemic nephropathy.
    Fickert P
    J Hepatol; 2024 Feb; 80(2):188-190. PubMed ID: 38013144
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Trauner M; Fickert P; Halilbasic E; Moustafa T
    Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The toxic effect of bile acid on rat liver by bile duct obstruction.
    Kim K; Kim HS; Kim HS; Jeong J; Kil KS; Yu BS
    J Toxicol Sci; 1998 Oct; 23 Suppl 4():662-3. PubMed ID: 9836192
    [No Abstract]   [Full Text] [Related]  

  • 18. Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants.
    Portincasa P; Grattagliano I; Testini M; Caruso ML; Wang DQ; Moschetta A; Calamita G; Vacca M; Valentini AM; Renna G; Lissidini G; Palasciano G
    Free Radic Biol Med; 2007 May; 42(9):1381-91. PubMed ID: 17395011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile Acids Are Important Contributors to AKI Associated with Liver Disease: CON.
    Allegretti AS; Belcher JM
    Kidney360; 2022 Jan; 3(1):21-24. PubMed ID: 35378020
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum bile acid analysis in dogs with experimentally induced cholestatic jaundice.
    Rutgers HC; Stradley RP; Johnson SE
    Am J Vet Res; 1988 Mar; 49(3):317-20. PubMed ID: 3358542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.